chr1-155293234-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 6P and 2B. PM1PM2PM5BP4_Moderate
The NM_000298.6(PKLR):āc.1379T>Cā(p.Val460Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000096 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V460M) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000298.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151962Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000254 AC: 64AN: 251492Hom.: 1 AF XY: 0.000235 AC XY: 32AN XY: 135922
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461894Hom.: 0 Cov.: 37 AF XY: 0.0000853 AC XY: 62AN XY: 727248
GnomAD4 genome AF: 0.000112 AC: 17AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74348
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 18, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 14, 2023 | - - |
Pyruvate kinase deficiency of red cells Uncertain:1
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Pyruvate kinase deficiency of red cells;C1863224:Pyruvate kinase hyperactivity Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 14, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at